Visual function during and after an acute central serous chorioretinopathy episode
- PMID: 35608741
- DOI: 10.1007/s10633-022-09875-x
Visual function during and after an acute central serous chorioretinopathy episode
Abstract
Purpose: To evaluate visual function parameters during and after an acute central serous chorioretinopathy (CSC) episode.
Methods: A prospective study included 19 fovea involving acute CSC patients with episode resolution within 3 months from the episode onset. Optical coherence tomography, best corrected visual acuity (BCVA), contrast sensitivity (CS), microperimetry (MP), and multifocal electroretinography (mfERG) were performed at baseline, 3 and 6 months from the episode onset. In a sub analysis, patients were divided into groups with greater (gMV, N = 9) and lower (lMV, N = 10) macular volume at presentation, and functional outcomes were observed.
Results: BCVA (p < 0.001), average CS (CS-A) (p < 0.001), average retinal sensitivity (MP-A) (p < 0.001), mfERG amplitude densities in the first and second ring (mfERG-A1, p < 0.001; mfERG-A2, p = 0.017), and implicit times in the first, second, and third ring (mfERG-IT1, p = 0.024; mfERG-IT2, p = 0.002; mfERG-IT3, p = 0.018) improved with episode resolution 3 months after the episode onset. From 3 to 6 months after the episode onset, only CS-A (p = 0.045) continued to improve. Patients in the gMV group had lower mfERG-A1 (p = 0.017) and central retinal sensitivity (MP-C, p = 0.05) 6 months from the episode onset.
Conclusions: Although all functional parameters mostly improve with CSC episode resolution, only CS continues to improve thereafter. Patients with greater MV at presentation have worse functional outcomes. Visual function impairment in acute CSC patients is confined to the topographical area of subretinal fluid detachment.
Keywords: Central serous chorioretinopathy; Contrast sensitivity; Electrophysiology; Functional outcomes; Microperimetry; mfERG.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Morphological and Functional Correlations in Acute Central Serous Chorioretinopathy.Doc Ophthalmol. 2024 Jun;148(3):145-153. doi: 10.1007/s10633-024-09969-8. Epub 2024 Mar 18. Doc Ophthalmol. 2024. PMID: 38498077 Free PMC article.
-
Correlation between functional and anatomical assessments by multifocal electroretinography and optical coherence tomography in central serous chorioretinopathy.Doc Ophthalmol. 2010 Apr;120(2):193-200. doi: 10.1007/s10633-010-9213-6. Doc Ophthalmol. 2010. PMID: 20066472
-
Multifocal electroretinography-assisted anatomical and functional evaluation of subthreshold green laser in acute central serous chorioretinopathy.Indian J Ophthalmol. 2021 Sep;69(9):2341-2346. doi: 10.4103/ijo.IJO_3401_20. Indian J Ophthalmol. 2021. PMID: 34427217 Free PMC article. Clinical Trial.
-
Evaluation of Acute Central Serous Chorioretinopathy Using Enhanced Depth Imaging Optical Coherence Tomography and Multifocal Electroretinography.Ophthalmologica. 2022;245(1):25-33. doi: 10.1159/000516097. Epub 2021 May 6. Ophthalmologica. 2022. PMID: 33957632
-
Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.Retina. 2011 Jul-Aug;31(7):1378-86. doi: 10.1097/FTD.0b013e31820beb02. Retina. 2011. PMID: 21836413 Clinical Trial.
Cited by
-
Effective Focal Laser Photocoagulation for Persistent Central Serous Chorioretinopathy: A Forgotten Technique.Klin Monbl Augenheilkd. 2024 Jun;241(6):768-771. doi: 10.1055/a-2227-4037. Epub 2023 Dec 12. Klin Monbl Augenheilkd. 2024. PMID: 38086411 Free PMC article. No abstract available.
-
Morphological and Functional Correlations in Acute Central Serous Chorioretinopathy.Doc Ophthalmol. 2024 Jun;148(3):145-153. doi: 10.1007/s10633-024-09969-8. Epub 2024 Mar 18. Doc Ophthalmol. 2024. PMID: 38498077 Free PMC article.
-
Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy.Life (Basel). 2023 May 16;13(5):1194. doi: 10.3390/life13051194. Life (Basel). 2023. PMID: 37240839 Free PMC article.
References
-
- Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118 - DOI
-
- Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I et al (2017) Acute central serous chorioretinopathy: factors influencing episode duration. Retina 37(10):1905–1915 - DOI
-
- Lourthai P, Bhurayanontachai P (2017) Pattern of contrast sensitivity changes in acute central serous chorioretinopathy. J Ophthalmol 2017:9053932 - DOI
-
- Roisman L, Ribeiro JC, Fechine FV, Lavinsky D, Moraes N, Campos M et al (2014) Does microperimetry have a prognostic value in central serous chorioretinopathy? Retina (Philadelphia, Pa) 34(4):713–718 - DOI
-
- Huang S, Wu D, Jiang F, Wu L, Liang J, Luo G et al (2002) The multifocal electroretinogram in central serous chorioretinopathy. Ophthalmic Physiological Optics 22(3):244–247 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources